Therapeutic effects of non-invasive, individualized, transcranial neuromodulation treatment for voiding dysfunction in multiple sclerosis patients: study protocol for a pilot clinical trial.
Khue TranZhaoyue ShiChristof KarmonikBlessy JohnHamida RajabSantosh A HelekarTimothy BooneRose KhavariPublished in: Pilot and feasibility studies (2021)
This trial is registered at ClinicalTrials.Gov ( NCT03574610 , 2 July 2018.) and Houston Methodist Research Institute IRB (PRO00019329).